Paclitaxel and Carboplatin Combination Chemotherapy in a Hemodialysis Patient with Advanced Ovarian Cancer

By Watanabe M.   Aoki Y.   Tomita M.   Sato T.   Takaki Y.   Kato N.   Kikuchi M.   Kase H.   Tanaka K.  

Gynecologic Oncology, Vol. 84, Iss. 2, 2002-02 ,pp. : 335-338

Elsevier

Access to resources Recommend Favorite

Is Age a Barrier to the Aggressive Treatment of Ovarian Cancer with Paclitaxel and Carboplatin?

By Higgins R.V.   Naumann R.W.   Gardner J.   Hall J.B.  

Gynecologic Oncology, Vol. 75, Iss. 3, 1999-12 ,pp. : 464-467

Elsevier

Access to resources Recommend Favorite

Paclitaxel and Cisplatin Combination Chemotherapy in Recurrent Epithelial Ovarian Cancer

By Goldberg J.M.   Piver M.S.   Hempling R.E.   Recio F.O.  

Gynecologic Oncology, Vol. 63, Iss. 3, 1996-12 ,pp. : 312-317

Academic Press

Access to resources Recommend Favorite

First-line chemotherapy with epidoxorubicin, paclitaxel, and carboplatin for the treatment of advanced epithelial ovarian cancer patients

By Romanini A.   Tanganelli L.   Carnino F.   Fanucchi A.   Lionetto R.   Pastorino S.   Cosio S.   Gadducci A.   Conte P.F.  

Gynecologic Oncology, Vol. 89, Iss. 3, 2003-06 ,pp. : 354-359

Elsevier

Access to resources Recommend Favorite

Safety and efficacy of aprepitant, ramosetron, and dexamethasone for chemotherapy-induced nausea and vomiting in patients with ovarian cancer treated with paclitaxel/carboplatin

By Choi Chel   Kim Min   Park Jin-Young   Yoon Aera   Kim Ha-Jeong   Lee Yoo-Young   Kim Tae-Joong   Lee Jeong-Won   Kim Byoung-Gie   Bae Duk-Soo  

Supportive Care in Cancer, Vol. 22, Iss. 5, 2014-05 ,pp. : 1181-1187

Springer Publishing Company

Access to resources Recommend Favorite